Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2004 042 436.6 |
96 | EP file number | EAKZ | 10 16 3527.4 |
97 | EP publication number | EPN | 2263694 |
54 | Designation/title | TI | Antitumormittel, enthaltend den Histon-deacetylase-inhibitor FK228 und den Topoisomerase-II-Inhibitor Doxorubicin |
51 | IPC main class | ICM (ICMV) | C07K 11/02 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/704 (2006.01), A61K 38/12 (2006.01) |
22 | DE application date | DAT | Sep 24, 2004 |
96 | EP application date | EAT | Sep 24, 2004 |
43 | Date of first publication | OT | Dec 22, 2010 |
| Date of publication of grant | PET | Jun 12, 2013 |
71/73 | Applicant/owner | INH | Astellas Pharma, Inc., Tokio/Tokyo, JP |
72 | Inventor | IN | Sasakawa, Yuka, Tokyo 103-8411, JP; Naoe, Yoshinori, Obu CityAichi 474-8511, JP |
74 | Representative | VTR | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
| Address for service | | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| JP 2003344315 Oct 2, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| JP 2003334340 Sep 25, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002263694 Searchable text:
EP000002263694 Original document:
EP000002263694B1 Searchable text:
EP000002263694B1 |
43 | Date of first publication | EVT | Dec 22, 2010 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 26, 2024 (Show all update days)(Hide all update days)- Sep 26, 2024
- Status: changed
- Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 24.09.2024: new
- Jul 26, 2024
- St.36: changed (technical change)
- Jul 11, 2024; Oct 3, 2023; Jul 7, 2022; Aug 21, 2021; Mar 5, 2021; Sep 21, 2020; Sep 19, 2019; Aug 21, 2019; Aug 6, 2019; Sep 18, 2018; Sep 28, 2017; Sep 28, 2016; Sep 26, 2015; Sep 30, 2014; Jun 26, 2014; May 22, 2014; Oct 8, 2013; Oct 3, 2013; Aug 8, 2013; Jul 23, 2013; Jul 20, 2013; Jun 18, 2013; Jun 13, 2013; Feb 15, 2013; Jul 27, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|